Process for the manufacture of diphenylalkylamines

    公开(公告)号:GB1025041A

    公开(公告)日:1966-04-06

    申请号:GB741864

    申请日:1964-02-21

    Applicant: HOECHST AG

    Inventor: KLOSA JOSEF

    Abstract: Diphenylalkamines of the formula and salts thereof, wherein R1 and R2 are each hydrogen, C1- 3 alkyl, C1- 3 alkoxy or halogen, R3 is hydrogen or C1- 3 alkyl and R4 is hydrogen, C1- 4 alkyl or an aralkyl group having 1-4 carbon atoms in the alkylene chain, which may be substituted in the phenyl nucleus by C1- 3 alkyl or C1- 3 alkoxy groups, or NR3R4 forms a morpholino, piperidino or pyrrolidino ring, and n is 1 or 2, are made by reacting an o -phenyl-o -hydroxy-alkylamine or an o -phenyl-o -halo-alkylamine or a styryt or cinnamyl-amine with an aryl compound C6H5R2, in the presence of a Friedel-Crafts catalyst, such as alminium-trichloride, gallium trichloride or boron tri fluoride. 1 - Phenyl - 1 - chloro - 3 - (1 - phenyl - propyl-(2) - amino) - propane is made by reacting 1 - phenyl - 1 - hydroxy - propylamine - (3) with phenylacetone, reducing with sodium boron hydride and treating the resulting 1-phenyl-1-hydroxy - 3 -(1 - phenyl - propyl - (2) - amino)-propane (hydrochloride) with thionyl chloride. 1 - Phenyl - 1 - chloropropylamine is made by the action of thionyl chloride on 1 -phenyl-1-hydroxy - propylamine. 1 - Phenyl - 1 - hydroxy-2 - (1 - phenyl - propyl - (2) - amino) - ethane is made by the reaction of styrene oxide with 1-phenyl - propylamine (2). 1 - Phenyl - 2 -cinnamylamino-propane hydrochloride is made by condensing cinnamic aldehyde with 1-phenyl-propyl-amine-(2) and reducing the resulting Schiffs base with sodium boron hydride.ALSO:Pharmaceutical preparations having action on the cardiac and circulatory system comprose compounds of the formula wherein R1 and R2 are each hydrogen, halogen or a C1-3 alkyl or alkoxy group, R3 is hydrogen or a C1-3 alkyl group and R4 is hydrogen, a C1-4 alkyl group or an aralkyl group having up to 4 carbon atoms in the alkylene chain optionally bearing C1-3 alkyl or alkoxy substituents on the alkylene chain, or NR3R4 forms a morpholino, piperidino or pyrrolidino ring and n is 1 or 2, or physiologically tolerable salts thereof with organic or inorganic acids, in admixture or conjunction with an excipient. The preparations may take forms suitable for parenteral or oral administration e.g. tablets.

Patent Agency Ranking